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REVIEW
URRENT
C
OPINION

The impact of COVID-19 on urology office visits
and adoption of telemedicine services
Mohit Butaney and Amarnath Rambhatla

Purpose of review
The purpose of this review article is to discuss the impact of Coronavirus Disease 2019 (COVID-19) on the
evolution of telemedicine use for urology office visits.
Recent findings
The COVID-19 pandemic has caused a dramatic change in the delivery of healthcare. Fraught with
numerous barriers previously, the need for healthcare delivery during a time of social distancing and
increased healthcare requirements drove the adoption of telemedicine forward. This ’trial period’ over the
last year has allowed us to appreciate the potential utility of telehealth-associated services in practice and
consider its role even after the pandemic. Multiple studies equating its utility to in-person visits whereas
simultaneously providing added convenience and cost-related savings have been published in the urologic
literature. Permanent regulatory changes will need to be implemented to allow us the flexibility to use
telehealth in the future.
Summary
It is clear that telemedicine is an effective strategy for delivery of healthcare under the right circumstances.
Although it initially started to fill a need out of necessity, it can help us effectively deliver healthcare as long
as the regulations surrounding telemedicine allow us to continue to use it. This period has been challenging
for healthcare delivery and led to policy changes that served as a catalyst to help us better understand this
previously underutilized resource.
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INTRODUCTION
The COVID-19 pandemic has caused a dramatic
shift in our system of healthcare delivery, initially
due to the necessary diversion of resources to manage COVID-19 patients, but also due to the continued appropriate need for social distancing.
Telemedicine or telehealth is the use of computers,
phones, wearable sensors, and other communication devices to exchange healthcare information
and advice between a patient and a provider typically via video visits, phone calls, emails, secure
messaging, or texts. Although telemedicine was
previously seen as a method to increase access to
rural areas, it has rapidly evolved and become an
essential part of healthcare delivery due to the relaxation of regulation at the federal and state level
which incentivized providers and health systems
to implement telehealth services. Without these
legislative changes, telemedicine would not be sustainable going forward and the majority of urologic
care would occur in metropolitan areas with
www.co-urology.com

traditional in person visits. In this review, we discuss
the adoption of telemedicine with a special emphasis on outpatient urological care.

POLICY SHIFT
The adoption of telemedicine has been slow due to a
variety of reasons but one of the primary reasons has
been with regards to healthcare policy and regulations. In the United States, Medicare coverage of
telehealth services began in 2001 with the enactment of the Balanced Budget Act of 1997 (BBA);
however, there were previously several restrictions
Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan,
USA
Correspondence to Mohit Butaney, MD, Vattikuti Urology Institute, Henry
Ford Hospital, 2799 W. Grand Boulevard, Detroit, MI 48202, USA.
Tel: +1 313 916 2600; fax: +1 313 916 2086;
e-mail: mbutane1@hfhs.org
Curr Opin Urol 2022, 32:152–157
DOI:10.1097/MOU.0000000000000957
Volume 32  Number 2  March 2022

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Telemedicine in COVID Butaney and Rambhatla

KEY POINTS
 The COVD-19 related public health emergency has
caused a dramatic shift in our system of
healthcare delivery.
 Several key policy changes regarding the use of
telemedicine during the pandemic have served as a
catalyst to utilize it in a widespread fashion.
 We now have a better understanding of the benefits of
telemedicine for all stakeholders involved including
patients, providers, and payers.
 Our insight into this experience is going to be crucial to
understand how we might be able to incorporate
telemedicine into our healthcare delivery system
postpandemic and we must advocate for permanent
policy changes to allow us to continue to use telehealth
in the future.

on telemedicine services that limited its widespread
use. The Department of Health and Human Services,
in response to the pandemic in March 2020, waived
several of these restrictions paving the way for the
necessary use of telemedicine during this time (1135
Waiver) [1 ,2 ]. Most importantly, the originating
site requirement, which previously required
patients to be located in a medical facility within
a rural area, was waived to allow patients to ’visit’
providers from any originating location including
their homes. Several other rules were relaxed allowing for the rapid utilization of telemedicine such as
the reimbursement to providers comparable to inoffice visits, increased ability of healthcare providers
to practice across state lines, ability of advanced
practice providers to utilize telehealth services in
delivering care, and the relaxation of privacy policies surrounding telehealth technologies. Apart
from federal regulations, it is important for providers to consider state laws when it comes to their
specific practice and these have followed suite to
allow for the practice of telemedicine. This trend is
also seen with private medical insurance companies
which have allowed providers to offer and bill for
telehealth services to new patients whereas previously these visits could only be used for established
care. The impact of COVID-19 internationally has
similarly led to dramatic policy changes allowing
countries with a telehealth framework in place to
make a leap in utilization and other countries to
rapidly build their infrastructure associated with
telemedicine [3].
Buoyed by the benefits of convenience and savings, telemedicine will continue to see a high
demand postpandemic. The key question going forward is how governments will handle these policies
&&

&&

and regulations and if they will make lasting
changes to facilitate telehealth. Future legislation
to incentivize telemedicine has the potential to
benefit patients as well as healthcare globally. However, there continue to be concerns about fraud,
overuse of care, and patient privacy associated with
telemedicine which were some of the barriers associated with initial telemedicine regulations.[4]
Active discussion regarding policy postpandemic
is underway; more recently the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act 2021 along with 42 other
bills was introduced in the 117th United States congress highlighting the political interest in making
some of the telemedicine flexibility permanent [5].
However, every country has its own limitations in
the current state of telemedicine so there will be
expected variability in how we build on this experience and move toward an improved and efficient
system of healthcare delivery.

ADOPTION OF TELEMEDICINE AND EARLY
TRENDS
The pandemic served as a catalyst for rapid and
necessary policy change which has helped us better
understand the utility of telemedicine. Data collected by the Centers for Disease Control and Prevention and the Health Resources and Services
Administration have been helpful to understand
the trends in telemedicine during this period.
Health centers utilization of telemedicine rose from
43% to 95% from 2019 to 2020 during the COVID19 pandemic [6 ]. The largest increase was seen in
April 2020, but telehealth continues to be used at a
higher rate than prepandemic levels. Preliminary
Medicare data between March and October 2020
showed that over 24.5 million out of 63 million
beneficiaries received a telemedicine visit during
the pandemic.[2 ] Similar trends were noted in
Medicaid or Children’s Health Insurance Program
data that showed an increase of 144,067,318 or
3,774% in services delivered through telehealth
when compared to prepandemic rates [7]. Nearly a
third of all visits during the early phase of the
pandemic were telemedicine visits [8]. Prior to the
pandemic, surgical specialties had been less likely to
use telehealth than other specialties but these specialties were quick to adopt telemedicine during the
pandemic [9].
&&

&&

TELEMEDICINE IN THE UROLOGY OFFICE
An increasing trend of utilization of telemedicine in
urology was noted even prior to the pandemic;
however, the slow adoption has been attributed to
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concerns regarding reimbursement, lack of resources/time, and liability issues cited as some of the
more significant barriers to implementation according to a survey done by the American Urological
Association’s (AUA) Telemedicine Workgroup
[10,11 ] Despite these barriers, a recent study using
a state insurance claims database showed urology as
leading the pack amongst surgical subspecialties
with telehealth conversions of encounters during
the pandemic [9]. Telemedicine has been shown to
be effective in a wide variety of sub-specialties
including urologic oncology, pediatric urology,
endourology, and andrology even prior to the recent
public health emergency [12 ,13–16]. However,
there has been a significant difference in its utilization starting in 2020.
In a survey conducted by the AUA Telemedicine
Workgroup prior to the pandemic, over 75% of
urologists saw a role for telemedicine with followup visits, 70% with postop visits, 52% with triage
prior to a new visit, and 36% with new patient visits
[11 ]. This study also reported that only 14% of
responding urologists were using telemedicine
despite 47% being associated with institutions promoting telemedicine. As per the 2020 AUA annual
census data, 71.5% of urologists confirmed participation in telemedicine, a significant increase from
the 11.9% in the previous year [17 ]. The top two
services used for which urologist received compensation were video visits or conferencing with
patients (93.9%) and telephone calls with patients
(77.3%). Consultation topics for which practicing
urologists utilized telemedicine were voiding dysfunction, benign prostatic hyperplasia, recurrent
urinary tract infections, stone disease, oncology/
PSA, erectile dysfunction, hematuria, and infertility
[17 ]. Interestingly, referring patients to telemedicine also served as a process to reduce appointment
wait times longer than 4 weeks [17 ]. Video visits
have clearly been found to be a safe and effective
substitute for in-person care across a broad range of
urologic diagnoses but ultimately it is up to the
discretion of the urologist to decide whether a specific patient can be evaluated by telehealth or needs
to be evaluated in person [18]. There still appears to
be significant variability in this without standardized guidelines across institutions.
The most important factor in this experience has
been that the primary stakeholder, the patient, has
been shown to be satisfied in a number of different
urological telemedical settings [12 ,19 ]. Telemedicine has been employed in situations that require
time-sensitive patient care and coordination such as
urologic oncology with studies showing high levels
of physician and patient satisfaction [20 ]. Shared
medical appointments in a group setting allow
&&
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providers to counsel a group of patients in a single
setting [21]. Virtual visits also allow multiple family
members to join from different locations to get an
improved appreciation of the care plan for their
relative which would allow for better coordinated
care. Additionally, while providers have had to
adapt to a new workflow, preliminary data has
shown a high level of satisfaction despite a reluctance to move away from in-person visits [22 ]. In
addition, telehealth can help reduce transportation
and parking costs as well as lead to less time off
needed from work or school.
Reducing the burden of in-person care and services in hospitals has been shown to help healthcare
efficiency [23]. Although initial workflow changes
need to be made in practices, provider efficiency
should theoretically increase during clinic with continued utilization and adapting to the increasingly
self-reliant setup. Costs associated with telemedicine visits compared to traditional in-person visits
have shown varied results but there are certainly
significant benefits of convenience of time and
transport that need to be taken into consideration
for both the patient and provider. It will be important to continue to assess cost-effectiveness postpandemic for specific clinical scenarios [24,25 ].
&
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ADVANCES IN TELEMEDICINE
The major limitation of telemedicine is the lack of
being able to conduct a physical exam or diagnostic
procedure that is often needed to make treatment
decisions. Initial telemedicine visits conducted from
rural medical facilities allowed for feedback from
available ancillary staff or other healthcare practitioners. This is not a possibility when a patient is
conducting a telemedicine visit from home. This has
allowed for the exploration of creative solutions
where an examination or procedure might be necessary to make the diagnosis. Lobo et al. showed that
trained advanced practice providers with real-time
urologist feedback for procedures such as cystoscopy
has allowed for improved access to care without
compromising on quality and further highlighting
the untapped utility of telemedicine [26]. The development of mobile apps (mHealth), home-based
diagnostics such as at-home semen analyses, wearable at home sensors with real time transmission of
data to physicians has ramped up and will likely
continue to be important noninvasive means of
supplementing the core telehealth services we are
now already familiar with [27–29]. Data from
McKinsey et al. has shown that investment in virtual
care and digital health is nearly three times the level
of venture capital digital health investment in 2017
promising a strong push to revolutionize this realm
Volume 32  Number 2  March 2022
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of healthcare [30]. Handheld exam kits that let
adults perform a guided ear exam on children to
aid physicians in diagnosing an infection, personalized apps to guide physical therapy and recovery
postorthopedic surgery, or at home ultrasounds for
pregnant women are all a reality now – progress in
other fields will further propel innovation in urology as well. However, many urologic conditions
exist where the initial evaluation is driven by subjective symptoms, laboratory, and/or imaging
results and a physical exam finding may not play
a large role in the final treatment decision.
Apart from efficiency in the outpatient setting,
groups have shown the successful utilization of clear
and easy to use algorithms to efficiently triage inpatient consults to telemedicine only or outpatient
clinic visits when appropriate to improve in-patient
efficiency as well [31]. Other concepts such as telesurgery, telementoring, and telerounding that have
been introduced over the past few decades have all
been undergoing reconsideration providing an
opportunity for us to rethink the way we currently
deliver care [32,33].

OVERCOMING BARRIERS
Apart from policy barriers, telemedicine has several
other hurdles to overcome to fully integrate into
practice postpandemic. Devices and platforms that
are compliant with privacy regulations across different systems while simultaneously being easily
adoptable by physicians and patients forms the basis
of effective telehealthcare. Up-front investments
and subscription fees may be a higher financial
burden to surmount for smaller practices [34 ].
The emergency policy changes initially allowed
for non-Health Insurance Portability and Accountability Act (HIPAA) compliant platforms, such as
FaceTime or Zoom, to be used if needed. Technology
manufacturers have rapidly evolved to ensure
HIPAA compliance and improve their platforms
based on growing requirements which will be beneficial to the use of telemedicine.
The telemedicine clinic has a very different
workflow and structure when compared to in-person visits. Getting all the information ahead of time,
including coordinating radiological and laboratory
studies close to their home is often a challenge in
some situations and requires significant administrative coordination. This has led to creation of a
telemedicine task force in most health systems
and health organizations with the intent of identifying potential pitfalls and coming up with solutions unique to telehealth concerns. One such
theoretical improvement in flow between in-office
visits compared to telemedicine is the reduction in

’no show’ rates. Interestingly, studies have continued to demonstrate a modest ’no-show’ rate with
telemedicine [13].
Although telemedicine has tremendous potential to really make a dent in the ’access to care’ issue
that has plagued the American healthcare system,
there will need to be a coordinated effort from the
government, payers, and healthcare systems, to make
a conscious effort to improve health literacy and
awareness as well as long term policy changes.
Approximately 90% of practicing urologists had a
primary practice location in a metropolitan area
which furthers the rural-urban divide [17 ,35]. In
order for patients living in a rural area to have access
to specialist care, regulations regarding originating
site requirement, new patient telemedicine services,
and reimbursement need to be made permanent.
Language barriers are also an important issue, however, these can potentially be circumvented and even
improved by the direct dialing in of a third-party
translator during a telemedicine visit. Tools essential
for telemedicine such as laptops and smart phones
are more readily available to patients and while new
telemedicine users might experience a technical difficulty during their first appointment, this barrier
should improve as patients become more familiar
with the platform. Circumstances where video visits
are not possible due to lack of access to devices or to
broadband internet can resort to telephone visits to
help improve patient care. Government support in
decreasing the ‘digital divide’ to improve access to wifi spots and hardware loan programs might also
contribute to improving healthcare for an already
vulnerable population [36].
&&

&

THE FUTURE OF UROLOGY PRACTICE
Only 11.9% of urologists stated that they used telemedicine prior to the pandemic but 71.5% reported
that they used telemedicine after the start of the
pandemic. Telehealth is the use of emails, texts,
secure messaging, phone calls, or video visits to
communicate with patients. It is likely that most
practicing urologists have used some form of this
communication even prior to the start of the pandemic. What has changed is that there is a more
widespread adoption of face-to-face video visits and
changes in policy that have brought telemedicine
into the limelight. Many urologic encounters can be
completed by obtaining a complete history, reviewing radiographic images and laboratory tests, and
appropriately counseling patients regarding treatment decisions without an in-office visit. These
situations are primed for telehealth. The traditional
in-office encounter still remains important especially when a physical exam or diagnostic testing
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such as cystoscopy or biopsy is needed. However,
telemedicine clearly has an important role going
forward and will add to healthcare efficiency, convenience, and economics. At the Vattikuti Urology
Institute we went from performing less than 100
telemedicine visits in 2019 to performing over 5000
in 2020 and remain on track for similar numbers in
2021. However, without continued legislative
action, there is a potential that we would return
to a system that only covers telehealth in a limited
setting. Physicians will need to be at the forefront to
advocate for permanent legislative change in these
policies which will allow us the flexibility to use
telehealth services to improve healthcare delivery in
the future.

CONCLUSION
The pandemic has been challenging for healthcare
but has served as a catalyst to help us better understand and utilize telemedicine. It is clear that telemedicine is an effective strategy for delivery of
urologic healthcare and will permanently affect
the way we practice medicine as long as regulations
surrounding the use of telemedicine become
long lasting.
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